Literature DB >> 16640343

Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides.

Daren Stephens1, Efrosini Barbayianni, Violetta Constantinou-Kokotou, Anna Peristeraki, David A Six, Jennifer Cooper, Richard Harkewicz, Raymond A Deems, Edward A Dennis, George Kokotos.   

Abstract

Inhibitors of the Group IVA phospholipase A(2) (GIVA cPLA(2)) and GVIA iPLA(2) are useful tools for defining the roles of these enzymes in cellular signaling and inflammation. We have developed inhibitors of GVIA iPLA(2) building upon the 2-oxoamide backbone that are uncharged, containing ester groups. Although the most potent inhibitors of GVIA iPLA(2) also inhibited GIVA cPLA(2), there were three 2-oxoamide compounds that selectively and weakly inhibited GVIA iPLA(2). We further show that several potent 2-oxoamide inhibitors of GIVA cPLA(2) containing free carboxylic groups (Kokotos et al. J. Med. Chem. 2002, 45, 2891-2893) do not inhibit GVIA iPLA(2) and are, therefore, selective GIVA cPLA(2) inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16640343      PMCID: PMC2544624          DOI: 10.1021/jm050993h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  46 in total

1.  Pyrrolidine inhibitors of human cytosolic phospholipase A(2).

Authors:  K Seno; T Okuno; K Nishi; Y Murakami; F Watanabe; T Matsuura; M Wada; Y Fujii; M Yamada; T Ogawa; T Okada; H Hashizume; M Kii; S Hara; S Hagishita; S Nakamoto; K Yamada; Y Chikazawa; M Ueno; I Teshirogi; T Ono; M Ohtani
Journal:  J Med Chem       Date:  2000-03-23       Impact factor: 7.446

Review 2.  Interfacial enzyme kinetics at the phospholipid/water interface: practical considerations.

Authors:  R A Deems
Journal:  Anal Biochem       Date:  2000-12-01       Impact factor: 3.365

3.  Studies of insulin secretory responses and of arachidonic acid incorporation into phospholipids of stably transfected insulinoma cells that overexpress group VIA phospholipase A2 (iPLA2beta ) indicate a signaling rather than a housekeeping role for iPLA2beta.

Authors:  Z Ma; S Ramanadham; M Wohltmann; A Bohrer; F F Hsu; J Turk
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

4.  Bis-2-oxo amide triacylglycerol analogues: a novel class of potent human gastric lipase inhibitors.

Authors:  S Kotsovolou; A Chiou; R Verger; G Kokotos
Journal:  J Org Chem       Date:  2001-02-09       Impact factor: 4.354

5.  Synthetic routes and lipase-inhibiting activity of long-chain alpha-keto amides.

Authors:  A Chiou; R Verger; G Kokotos
Journal:  Lipids       Date:  2001-05       Impact factor: 1.880

6.  Involvement of calcium-independent phospholipase A2 in uterine stromal cell phospholipid remodelling.

Authors:  H Birbes; S Drevet; J F Pageaux; M Lagarde; C Laugier
Journal:  Eur J Biochem       Date:  2000-12

7.  A pyrrolidine-based specific inhibitor of cytosolic phospholipase A(2)alpha blocks arachidonic acid release in a variety of mammalian cells.

Authors:  F Ghomashchi; A Stewart; Y Hefner; S Ramanadham; J Turk; C C Leslie; M H Gelb
Journal:  Biochim Biophys Acta       Date:  2001-08-06

8.  Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2.

Authors:  Karin Killermann Lucas; Camilla I Svensson; Xiao-Ying Hua; Tony L Yaksh; Edward A Dennis
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

Review 9.  Structure and mechanism of human cytosolic phospholipase A(2).

Authors:  A Dessen
Journal:  Biochim Biophys Acta       Date:  2000-10-31

10.  Synthesis of 2-Oxo amide triacylglycerol analogues and study of their inhibition effect on pancreatic and gastric lipases.

Authors:  G Kokotos; R Verger; A Chiou
Journal:  Chemistry       Date:  2000-11-17       Impact factor: 5.236

View more
  28 in total

Review 1.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

2.  Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and Structure-Activity Relationships.

Authors:  Varnavas D Mouchlis; Dimitris Limnios; Maroula G Kokotou; Efrosini Barbayianni; George Kokotos; J Andrew McCammon; Edward A Dennis
Journal:  J Med Chem       Date:  2016-04-28       Impact factor: 7.446

3.  Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2.

Authors:  George Kokotos; Yuan-Hao Hsu; John E Burke; Constantinos Baskakis; Christoforos G Kokotos; Victoria Magrioti; Edward A Dennis
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

4.  Phospholipase A2 superfamily members play divergent roles after spinal cord injury.

Authors:  Rubèn López-Vales; Nader Ghasemlou; Adriana Redensek; Bradley J Kerr; Efrosini Barbayianni; Georgia Antonopoulou; Constantinos Baskakis; Khizr I Rathore; Violetta Constantinou-Kokotou; Daren Stephens; Takao Shimizu; Edward A Dennis; George Kokotos; Samuel David
Journal:  FASEB J       Date:  2011-08-25       Impact factor: 5.191

5.  2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity.

Authors:  Georgia Antonopoulou; Victoria Magrioti; Maroula G Kokotou; Aikaterini Nikolaou; Efrosini Barbayianni; Varnavas D Mouchlis; Edward A Dennis; George Kokotos
Journal:  Bioorg Med Chem       Date:  2016-07-27       Impact factor: 3.641

6.  A novel monoacylglycerol lipase inhibitor with analgesic and anti-inflammatory activity.

Authors:  Victoria Magrioti; George Naxakis; Dimitra Hadjipavlou-Litina; Alexandros Makriyannis; George Kokotos
Journal:  Bioorg Med Chem Lett       Date:  2008-09-12       Impact factor: 2.823

7.  Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A(2) enzymes.

Authors:  Georgia Antonopoulou; Efrosini Barbayianni; Victoria Magrioti; Naomi Cotton; Daren Stephens; Violetta Constantinou-Kokotou; Edward A Dennis; George Kokotos
Journal:  Bioorg Med Chem       Date:  2008-11-01       Impact factor: 3.641

8.  2-Oxoamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudodipeptides.

Authors:  Efrosini Barbayianni; Daren Stephens; Andrej Grkovich; Victoria Magrioti; Yuan-Hao Hsu; Panagiotis Dolatzas; Dimitrios Kalogiannidis; Edward A Dennis; George Kokotos
Journal:  Bioorg Med Chem       Date:  2009-05-03       Impact factor: 3.641

9.  Synthesis of polyfluoro ketones for selective inhibition of human phospholipase A2 enzymes.

Authors:  Constantinos Baskakis; Victoria Magrioti; Naomi Cotton; Daren Stephens; Violetta Constantinou-Kokotou; Edward A Dennis; George Kokotos
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

10.  Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis.

Authors:  Athena Kalyvas; Constantinos Baskakis; Victoria Magrioti; Violetta Constantinou-Kokotou; Daren Stephens; Rubèn López-Vales; Jian-Qiang Lu; V Wee Yong; Edward A Dennis; George Kokotos; Samuel David
Journal:  Brain       Date:  2009-02-13       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.